Bicara Therapeutics (BCAX) Treasury Shares (2023 - 2026)

Bicara Therapeutics has reported Treasury Shares for 4 years, with the latest figure at $9361.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $9361.0; the trailing twelve-month figure through Mar 2026 stood at $9361.0 (changed N/A YoY), and the FY2025 full-year result was $9361.0, changed 0.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $9361.0, roughly flat from $9361.0 in the prior quarter.
• The five-year high for Treasury Shares was $47199.0 in Q4 2023, with the low at $6947.0 in Q3 2024.
• Historically, Treasury Shares has averaged $16445.8 across 4 years, with a median of $9361.0 in 2024.
• Annual changes were most pronounced in 2024 — Treasury Shares slumped 80.17% — and 2025, when it changed 0.0%.
• Bicara Therapeutics' Treasury Shares stood at $47199.0 in 2023, then tumbled by 80.17% to $9361.0 in 2024, then changed by 0.0% to $9361.0 in 2025, then changed by 0.0% to $9361.0 in 2026.
• The last three Treasury Shares figures came in at $9361.0 (Q1 2026), $9361.0 (Q4 2025), and $9361.0 (Q4 2024), per Business Quant data.